In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents
- 31 December 1995
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 16 (17) , 1305-1312
- https://doi.org/10.1016/0142-9612(95)91045-z
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- F XIIAnnals of Hematology, 1990
- Effects of plasma kallikrein and bradykinin infusions into pigs on plasma fibrinolytic variables and urinary excretion of thromboxane and prostacyclin metabolitesFibrinolysis, 1988
- Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.Journal of Clinical Investigation, 1984
- In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate EBlood, 1984
- Mechanisms of activation of the classical pathway of complement by Hageman factor fragment.Journal of Clinical Investigation, 1983
- The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.Journal of Clinical Investigation, 1978
- The purification of a human plasma kallikrein with weak plasminogen activator activityThrombosis Research, 1978
- Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.The Journal of Experimental Medicine, 1978
- Activation of bovine factor VII by hageman factor fragmentsBlood, 1977
- Structural Changes Accompanying Enzymatic Activation of Human Hageman FactorJournal of Clinical Investigation, 1974